Skip to main content
Clinical Trials/NL-OMON53243
NL-OMON53243Not yet recruitingNot Applicable

Patients with Angina and MicrOvaScular DysfunctIon treaTed with cardiac non-InVasivE SHOCK wave therapy, a first in man pioneering trial -POSITIVE SHOCK- - POSITIVE SHOCK trial

cardiologie0 sites40 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. Stable Angina, defined as: - Angina with exercise or rest - Exertional
  • dyspnea 2. Age >=18 years 3. Angina without flow limiting CAD defined as
  • epicardial stenosis <50% or FFR >0.80 4. presence of MVD defined as

Exclusion Criteria

  • * noncardiac origin of chest pain, such as gastrointestinal or musculoskeletal
  • * Recent (<3 months) myocardial infarction * Severe aortic valve stenosis/
  • elevated LVEDP * History of coronary artery bypass graft * Known cardiomyopathy
  • or myocarditis * Bad acoustic windows in supine position * LV thrombus * ICD/
  • pacemaker * Extra-cardiac illness that is expected to limit survival to less
  • than 1 years * Active participation in another trial * Unable to give informed
  • consent or potential for noncompliance with the study protocol in the judgment
  • of the investigator * Pregnant at the time of screening or unwilling to use
  • effective birth control measures

Investigators

Similar Trials

Patients with Angina and MicrOvaScular... | Clinical Trial